The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-[5-Bromo-2-(4-methoxy-benzyloxy)-phenyl]-4,5-dihydro-isoxazole-5-carboxylic acid methyl ester ID: ALA313739
PubChem CID: 44318327
Max Phase: Preclinical
Molecular Formula: C19H18BrNO5
Molecular Weight: 420.26
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)C1CC(c2cc(Br)ccc2OCc2ccc(OC)cc2)=NO1
Standard InChI: InChI=1S/C19H18BrNO5/c1-23-14-6-3-12(4-7-14)11-25-17-8-5-13(20)9-15(17)16-10-18(26-21-16)19(22)24-2/h3-9,18H,10-11H2,1-2H3
Standard InChI Key: WDYUQOUGGLQNRI-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
2.5667 1.8833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7292 1.0708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8875 1.7333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0167 0.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2792 2.2833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5542 0.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6917 1.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0167 -0.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2917 1.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7292 -0.5917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9542 2.6958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3000 -0.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5792 0.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7292 -1.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2500 1.2958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0042 -1.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5792 -2.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5792 -0.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 1.0583 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1.2917 -1.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0042 -2.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2917 -3.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5792 -1.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 -3.0750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0417 1.5083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 -3.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 5 1 0
4 2 1 0
5 1 1 0
6 2 1 0
7 3 1 0
8 4 1 0
9 4 2 0
10 8 1 0
11 7 2 0
12 8 2 0
13 9 1 0
14 10 1 0
15 7 1 0
16 14 1 0
17 22 1 0
18 13 2 0
19 13 1 0
20 16 2 0
21 16 1 0
22 21 2 0
23 20 1 0
24 17 1 0
25 15 1 0
26 24 1 0
3 6 1 0
12 18 1 0
17 23 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 420.26Molecular Weight (Monoisotopic): 419.0368AlogP: 3.70#Rotatable Bonds: 6Polar Surface Area: 66.35Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.62CX LogP: 3.87CX LogD: 3.87Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.67Np Likeness Score: -0.72
References 1. Sammelson RE, Ma T, Galietta LJ, Verkman AS, Kurth MJ.. (2003) 3-(2-Benzyloxyphenyl)isoxazoles and isoxazolines: synthesis and evaluation as CFTR activators., 13 (15): [PMID:12852954 ] [10.1016/s0960-894x(03)00482-7 ]